1.
Shambhavi S, DiVanna M, Sharma S, Singh H, Gupta A, Pompa T, et al. Demographic Variations in Immune Checkpoint Inhibitor Adverse Events: A Real-World Study. World J Oncol [Internet]. 2025 Jan. 1 [cited 2026 Feb. 1];16(5):439-45. Available from: https://wjon.elmerpub.com/wjon/article/view/2612